India vs Uganda: The number of people with susceptibility test result for rifampicin
India
76.27
in 2021
Uganda
74.76
in 2021
India rank
98th
Uganda rank
101st
The number of people with susceptibility test result for rifampicin over time
- India
- Uganda
How they compare
India currently reports 76.27 against 74.76 in Uganda, a difference of 1.51.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Uganda ahead.
India ranks 98th and Uganda ranks 101st of 146 countries.
Across the 2 decades both report, India averaged higher in 1 and Uganda in 1.
Head to head by decade
| Decade | India | Uganda | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 51.98 | 82.7 | 30.72 | Uganda |
| 2020s | 87.02 | 68.69 | 18.33 | India |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, India or Uganda?
- India, at 76.27 against 74.76 in Uganda as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between India and Uganda?
- 1.51, with India ahead.
- How many years of comparable data are there for India and Uganda?
- 5 years are reported by both, from 2017 to 2021.
- How do India and Uganda rank globally for the number of people with susceptibility test result for rifampicin?
- India ranks 98th and Uganda ranks 101st of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.